Melanoma Clinical Trials

Showing 381-400 of 1,477 trials

Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

NCT00535314

The primary purpose of the study is to determine the proportion of patients without progression at 6-months in patients with unresectable Stage III or Stage IV melanoma who are taking RTA 402.

Malignant Melanoma

Biogen

Active Not RecruitingPhase 1

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

This study will evaluate safety, pharmacodynamics and biomarkers of subcutaneous (SC) DK210(EGFR) given as monotherapy and in combination with immunotherapy, chemotherapy or radiation.

CancerSolid TumorColorectal Cancer+6 more

DEKA Biosciences39 participantsStarted Apr 2023

Duarte, California, United States • Manhasset, New York, United States • Oklahoma City, Oklahoma, United States +4 more locations

RECRUITING

Multi-modal Quantitative Imaging of the Skin

NCT06989216

This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.

Skin CancerSkin DiseasesAtopic Dermatitis+4 more

HJN Sverige AB/Neko Health8,000 participantsStarted Feb 2023

Stockholm, Sweden • Stockholm, Sweden • Stockholm, Sweden

Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Multi-modal Quantitative Imaging of the Skin

Related Searches

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Adjuvant Melatonin for Uveal Melanoma

Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.

Brodalumab in the Treatment of Immune-Related Adverse Events

Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

A Study of SEA-CD40 Given With Other Drugs in Cancers

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma

Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin

Mentored Community Gardening for Individuals With Skin Cancer

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases